Medscape: Mild Liver Enzyme Increases Seen in COVID-19 Patients in China
UC digestive diseases expert discusses COVID-19's impact on the liver
Close to 30% of COVID-19 patients presented with mildly elevated liver enzymes in a retrospective study in China. Enzyme levels did not rise significantly during hospitalization and no patients experienced liver failure, however. Kenneth Sherman, MD, PhD, Director of the UC Division of Digestive Diseases and UC Health physician, spoke with journalist Marilynn Larkin about possible liver damage associated with SARS-CoV-2 and how pre-existing liver disease could make individuals more susceptible to infection leading to COVID-19.
Read the entire interview online.
Learn more about Sherman's COVID-19 research.
Featured image at top: Kenneth Sherman, MD, PhD, shown in the UC College of Medicine. Photo/Colleen Kelley/UC Creative + Brand.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
These teeny spiders are social media stars
August 28, 2026
The New York Times turned to a University of Cincinnati professor to explain the appeal of jumping spiders on social media.
An internal divide among unions on AI impacts the Wisconsin gubernatorial race
August 28, 2026
Anne Lofaso, a professor in the Donald P. Klekamp College of Law at UC, spoke with Wisconsin Public Radio, about the schism among unions over AI and whether it is a plus, a negative, or somewhere in between when looking at job creation.
On-site training in Speech & Hearing Clinic sets UC’s programs apart
August 27, 2026
At the University of Cincinnati’s Speech & Hearing Clinic, Doctor of Audiology and Speech-Language Pathology graduate students gain real-world experience while providing free speech and hearing services to the community.